Jpmorgan Chase & CO Petmed Express Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Petmed Express Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 23,481 shares of PETS stock, worth $107,542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,481
Previous 87,952
73.3%
Holding current value
$107,542
Previous $356,000
75.84%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PETS
# of Institutions
102Shares Held
9.52MCall Options Held
39.6KPut Options Held
137K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.3MShares$5.97 Million0.01% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA1.09MShares$5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$4.95 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA606KShares$2.78 Million0.01% of portfolio
-
Black Rock Inc. New York, NY556KShares$2.55 Million0.0% of portfolio
About PETMED EXPRESS INC
- Ticker PETS
- Exchange NASDAQ
- Sector Healthcare
- Industry Pharmaceutical Retailers
- Shares Outstandng 21,013,800
- Market Cap $96.2M
- Description
- PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...